Recombinant Human CCDC134 protein
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human CCDC134 protein is a Human Full Length protein, in the 23 to 229 aa range, expressed in HEK 293 cells, with >95%, < 0.1 EU/µg endotoxin level, suitable for SDS-PAGE, HPLC.
View Alternative Names
Coiled-coil domain-containing protein 134, CCDC134
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Specifications
Form
Lyophilized
Additional notes
The purity of ab194049 was determined by SEC-HPLC and reducing SDS-PAGE.
General info
Function
In extracellular secreted form, promotes proliferation and activation of CD8(+) T cells, suggesting a cytokine-like function (PubMed : 25125657). Enhances cytotoxic anti-tumor activity of CD8(+) T cells (PubMed : 25125657). May inhibit ERK and JNK signaling activity (PubMed : 18087676, PubMed : 23070808). May suppress cell migration and invasion activity, via its effects on ERK and JNK signaling (PubMed : 23070808). Has a critical role in the regulation of osteogenesis and bone development (PubMed : 32181939).. In the nucleus, enhances stability of the PCAF histone acetyltransferase (HAT) complex member TADA2A and thus promotes PCAF-mediated H3K14 and H4K8 HAT activity. May inhibit TADA2A-mediated TP53/p53 'Lys-321' acetylation, leading to reduced TP53 stability and transcriptional activity. May also promote TADA2A-mediated XRCC6 acetylation thus facilitating cell apoptosis in response to DNA damage.
Sequence similarities
Belongs to the CCDC134 family.
Post-translational modifications
O-glycosylated, with additional sialic acid modifications.
Subcellular localisation
Nucleus
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com